DarioHealth to Participate in the Virtual 18th Annual Craig-Hallum Institutional Investor Conference
NEW YORK, May 26, 2021 /PRNewswire/ -- DarioHealth (Formerly Known As LabStyle Innovations). (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in the 18th Annual Craig-Hallum Institutional Investor Conference, which is being held virtually on Wednesday, June 2.
Erez Raphael, Chief Executive Officer, and Rick Anderson, President and General Manager of North America, will host investor 1x1 and small group meetings with registered attendees.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario's next-generation, AI-powered, digital therapeutic solutions support more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Dario offers one of the highest-rated diabetes and hypertension solutions on the market. The company's cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets, using a performance-based approach to improve its users' health. Dario makes the right thing to do the easy thing to do. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.
DarioHealth Corporate Contact:
Investor Relations Contact:
SOURCE DarioHealth Corp.
Company Codes: Stuttgart:LS1P, NASDAQ-SMALL:DRIO, Munich:LS1P, Berlin:LS1P